| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA658407 | F | Compound was evaluated against Human cell line CNS SF-295 | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
| 2. | ALA658408 | F | Cytotoxicity against CNS SF-295 cell lines | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
| 3. | ALA658409 | F | In vitro cytotoxicity against CNS SF-295 human tumors following a 2 day exposure. | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
| 4. | ALA858300 | F | Cytotoxicity against human CNS SF-295 cell line | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 5. | ALA658410 | F | Tested for cytostatic activity against Central nervous system SF-295 cell line of NCI 60 tumor cell line panel | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 6. | ALA658128 | F | In vitro growth inhibition against CNS cancer SF-295 cell line was reported. | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
| 7. | ALA658129 | F | Log of molar concentration leading to 50% cell death against CNS cancer SF-295 cell line was reported | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
| 8. | ALA658130 | F | In vitro total growth inhibition against CNS cancer SF-295 cell lines was reported. | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
| 9. | ALA654307 | F | Compound was tested in vitro for its antitumor activity against CNS cancer cell line SF-295 (50% growth inhibition of tumor cells after 48 hr exposure ) | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
| 10. | ALA883904 | F | Evaluated for growth inhibition (anticancer activity) in Human CNS cancer SF-295 cell line | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 11. | ALA696912 | F | Evaluated for growth inhibition (anticancer activity) of Human CNS cancer SF-295 cell line | Homo sapiens | 7 | cell-based format | Scientific Literature | ||
| 12. | ALA805825 | F | Compound was tested in vitro for growth inhibition of SF 295 cells derived from CNS tumor | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 13. | ALA802842 | F | Tested for cytotoxic activity against CNS cancer SF-295 cell line | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 14. | ALA798838 | F | Inhibition of growth of SF-295 CNS cancer cell line | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 15. | ALA798839 | F | Inhibition of in vitro tumor cell growth of SF-295, CNS tumor cell line | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
| 16. | ALA798840 | F | Cytotoxicity against NCI tumor panel, SF-295 CNS cancer cell line | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 17. | ALA806629 | F | Concentration of compound that cause 50% cytotoxicity of SF-295 CNS cancer cell line | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 18. | ALA806630 | F | Compound was tested for inhibition of SF-295 human CNS cancer cell line | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 19. | ALA804059 | F | Inhibition of SF-295 human Central nervous system (CNS) cell proliferation | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 20. | ALA804060 | F | Cytotoxic activity against SF-295 CNS cancer cell line | Homo sapiens | 4 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!